Based on the provided data and recent market activity, EPAM appears to be reasonably valued with some concerns. The stock has declined 21.97% following its Q4 and full-year 2024 earnings report and disappointing 2025 guidance. Current P/E ratio of 42.12x and EV/EBITDA of 24.50x show moderate premium valuation compared to historical levels. Revenue declined slightly from $4.82B in 2022 to $4.69B in 2023, while net income remained relatively flat at $417M. Gross margin contracted from 29.97% to 28.62%, indicating some operational pressure.
Analyst Sentiment
Recent analyst actions show mixed views but generally positive:
- Morgan Stanley raised target to $256 with Equal Weight rating
- JP Morgan maintains Buy rating with $274 target
- Barclays maintains Buy rating with $290 target
Technical Analysis
The stock is currently trading around $208, significantly below its 52-week high of $317.50. While showing some stabilization after recent declines, technical indicators suggest continued near-term pressure.
Key Concerns
- Declining margins
- Weak guidance for 2025
- Recent significant stock price decline
- Insider selling activity, including SVP's sale of 6,758 shares
The stock appears fairly valued at current levels given the growth challenges and margin pressure, though strong analyst support and solid balance sheet provide some comfort. The current valuation multiples reflect the market's reduced expectations while maintaining premium to account for EPAM's market position and expertise in digital transformation services.